Status:
COMPLETED
Cone Beam CT for Daily Image Guidance - Prostate Cancer
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
18+ years
Phase:
PHASE2
Brief Summary
Conformal dose escalated radiation therapy (CRT) is standard treatment for patients with low and intermediate risk prostate cancer. CRT requires accurate daily localization of the prostate prior to tr...
Eligibility Criteria
Inclusion
- Diagnosis of adenocarcinoma of the prostate
- Patient undergoing dose escalated conformal external beam radiation therapy
- Low or intermediate risk prognostic factors (PSA 20 or less, Gleason score \<8, Clinical T category \<T3, Clinical N category 0 or X, M category 0 or X
- Age 18 years or older
- ECOG performance status 0 or 1
- Informed consent
Exclusion
- Inflammatory bowel disease or collagen vascular disease
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00188786
Start Date
April 1 2005
End Date
April 1 2010
Last Update
February 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9